Adjuvant Apatinib in Nasopharyngeal Carcinoma With Residual Epstein-Barr Virus DNA After Radiation Therapy: A Biomarker-Driven, Phase 2 Trial.
Liu X, Guo L, Xie FY, Hu WH, Chen MY, He QM, Xu ZM, Zhang CQ, Peng YL, Tang LL, Mao YP, Sun R, Li JB, Argiris A, Hui EP, Sun Y, Ma J.
Liu X, et al. Among authors: hui ep.
Int J Radiat Oncol Biol Phys. 2022 Aug 1;113(5):1063-1071. doi: 10.1016/j.ijrobp.2022.04.049. Epub 2022 May 9.
Int J Radiat Oncol Biol Phys. 2022.
PMID: 35550406
Clinical Trial.